An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

Abbreviated New Drug Application (ANDA): 220783
Company: ZYDUS PHARMS

Products on ANDA 220783

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
ROMIDEPSIN	ROMIDEPSIN	10MG/VIAL	POWDER;INTRAVENOUS	Prescription	AP	No	No

Approval Date(s) and History, Letters, Labels, Reviews for ANDA 220783

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
10/19/2026	ORIG-1	Approval		STANDARD		Label is not available on this site.

Therapeutic Equivalents for ANDA 220783

ROMIDEPSIN

POWDER;INTRAVENOUS; 10MG/VIAL
TE Code = AP

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	RLD	TE Code	Application No.	Company
ISTODAX	ROMIDEPSIN	10MG/VIAL	POWDER;INTRAVENOUS	Prescription	Yes	AP	022393	BRISTOL-MYERS
ROMIDEPSIN	ROMIDEPSIN	10MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	206254	FRESENIUS KABI USA
ROMIDEPSIN	ROMIDEPSIN	10MG/VIAL	POWDER;INTRAVENOUS	Prescription	No	AP	220783	ZYDUS PHARMS

Top